These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients. Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984 [TBL] [Abstract][Full Text] [Related]
5. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report. Elgudin L; Hall Y; Schubert D Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346 [TBL] [Abstract][Full Text] [Related]
6. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report. Patel N; Landry KB; Fargason RE; Birur B Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203 [TBL] [Abstract][Full Text] [Related]
7. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature. Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937 [No Abstract] [Full Text] [Related]
8. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders. Lewis C; Tesar GE; Dale R Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969 [TBL] [Abstract][Full Text] [Related]
9. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting]. Fassi G; Igoa A; Liste OA Vertex; 2008; 19(82):371-7. PubMed ID: 19424520 [TBL] [Abstract][Full Text] [Related]
10. Clinical alertness to valproic acid-induced hyperammonemia--two case reports. Shan JC; Hsieh MH; Liu CC; Wen CC; Liu CM J Psychopharmacol; 2010 Jun; 24(6):943-5. PubMed ID: 19304858 [No Abstract] [Full Text] [Related]
12. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting. Kimmel RJ; Irwin SA; Meyer JM Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman. Mallet L; Babin S; Morais JA Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109 [TBL] [Abstract][Full Text] [Related]
14. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient. Lin MW; Chang C; Yeh CB; Tai YM; Chang HA; Kao YC; Tzeng NS Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641 [No Abstract] [Full Text] [Related]
15. Valproate-induced hyperammonaemia. Raja M; Azzoni A J Clin Psychopharmacol; 2002 Dec; 22(6):631-3. PubMed ID: 12454569 [No Abstract] [Full Text] [Related]
17. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting. Dawson LP; Lee SJ; Hollander YS Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174 [No Abstract] [Full Text] [Related]
18. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy. Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579 [TBL] [Abstract][Full Text] [Related]